Literature DB >> 23540867

Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.

Anish Thomas1, Liqiang Xi, Corey A Carter, Arun Rajan, Sean Khozin, Eva Szabo, Phillip A Dennis, Giuseppe Giaccone, Mark Raffeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23540867      PMCID： PMC5002228          DOI： 10.1016/j.cllc.2013.01.005

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  15 in total

1.  Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Authors:  Daphne W Bell; Ira Gore; Ross A Okimoto; Nadia Godin-Heymann; Raffaella Sordella; Roseann Mulloy; Sreenath V Sharma; Brian W Brannigan; Gayatry Mohapatra; Jeff Settleman; Daniel A Haber
Journal:  Nat Genet       Date:  2005-10-30       Impact factor: 38.330

2.  EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Authors:  Susumu Kobayashi; Titus J Boggon; Tajhal Dayaram; Pasi A Jänne; Olivier Kocher; Matthew Meyerson; Bruce E Johnson; Michael J Eck; Daniel G Tenen; Balázs Halmos
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

3.  Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

Authors:  Michio Inukai; Shinichi Toyooka; Sachio Ito; Hiroaki Asano; Shuji Ichihara; Junichi Soh; Hiroshi Suehisa; Mamoru Ouchida; Keisuke Aoe; Motoi Aoe; Katsuyuki Kiura; Nobuyoshi Shimizu; Hiroshi Date
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

4.  Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants.

Authors:  Brian J Skaggs; Mercedes E Gorre; Ann Ryvkin; Michael R Burgess; Yongming Xie; Yun Han; Evangelia Komisopoulou; Lauren M Brown; Joseph A Loo; Elliot M Landaw; Charles L Sawyers; Thomas G Graeber
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-12       Impact factor: 11.205

5.  A rigorous and comprehensive validation: common genetic variations and lung cancer.

Authors:  Ping Yang; Yafei Li; Ruoxiang Jiang; Julie M Cunningham; Yan Li; Fang Zhang; Mariza de Andrade
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

6.  Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer.

Authors:  Ying Gao; Alisa M Goldstein; Dario Consonni; Angela C Pesatori; Sholom Wacholder; Margaret A Tucker; Neil E Caporaso; Lynn Goldin; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

Review 7.  EGFR T790M mutation: a double role in lung cancer cell survival?

Authors:  Kenichi Suda; Ryoichi Onozato; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  J Thorac Oncol       Date:  2009-01       Impact factor: 15.609

8.  Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report.

Authors:  Nicolas Girard; Emil Lou; Christopher G Azzoli; Rekha Reddy; Mark Robson; Megan Harlan; Irene Orlow; Yasushi Yatabe; Khedoudja Nafa; Marc Ladanyi; Agnes Viale; Mark G Kris; Gregory Riely; Vincent Miller; Robert J Klein; Keitaro Matsuo; William Pao
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

9.  EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity.

Authors:  Haris Vikis; Mitsuo Sato; Michael James; Daolong Wang; Yian Wang; Min Wang; Dongmei Jia; Yan Liu; Joan E Bailey-Wilson; Christopher I Amos; Susan M Pinney; Gloria M Petersen; Mariza de Andrade; Ping Yang; Jonathan S Wiest; Pamela R Fain; Ann G Schwartz; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Elena Kupert; Daniela Seminara; Avinash Viswanathan; Ramaswamy Govindan; John Minna; Marshall W Anderson; Ming You
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

10.  Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors.

Authors:  Lucia Regales; Marissa N Balak; Yixuan Gong; Katerina Politi; Ayana Sawai; Carl Le; Jason A Koutcher; David B Solit; Neal Rosen; Maureen F Zakowski; William Pao
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240
View more
  11 in total

Review 1.  Germline mutations predisposing to non-small cell lung cancer.

Authors:  Gerald H Clamon; Aaron D Bossler; Taher Abu Hejleh; Muhammad Furqan
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

2.  Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer.

Authors:  Chunxiang Li; Yalong Wang; Kai Su; Yu Liu; Liyu Wang; Bo Zheng; Na Yan; Dawei Yuan; Yanxiang Zhang; Liyan Xue; Shugeng Gao; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-04

3.  Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.

Authors:  Ran Huo; Jinghua Li; Xiaofang Li; Junping Shi; Kunjie Wang; Jin Jiao; Yanhong Shang
Journal:  Oncologist       Date:  2020-06-11       Impact factor: 5.837

4.  Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.

Authors:  Anish Thomas; Yuanbin Chen; Tinghui Yu; Marko Jakopovic; Giuseppe Giaccone
Journal:  Front Oncol       Date:  2015-05-26       Impact factor: 6.244

Review 5.  Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies.

Authors:  Anthony M Musolf; Claire L Simpson; Mariza de Andrade; Diptasri Mandal; Colette Gaba; Ping Yang; Yafang Li; Ming You; Elena Y Kupert; Marshall W Anderson; Ann G Schwartz; Susan M Pinney; Christopher I Amos; Joan E Bailey-Wilson
Journal:  Genes (Basel)       Date:  2017-01-17       Impact factor: 4.096

Review 6.  Inherited lung cancer: a review.

Authors:  Viviane Teixeira Loiola de Alencar; Maria Nirvana Formiga; Vladmir Cláudio Cordeiro de Lima
Journal:  Ecancermedicalscience       Date:  2020-01-29

Review 7.  Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.

Authors:  Yue I Cheng; Yun Cui Gan; Dan Liu; Michael P A Davies; Wei Min Li; John K Field
Journal:  BMC Cancer       Date:  2019-11-08       Impact factor: 4.430

8.  Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients.

Authors:  Jie Yang; Hefei Li; Ben Li; Wei Li; Qiang Guo; Ling Hu; Zizheng Song; Bin Zhou
Journal:  Front Oncol       Date:  2021-04-07       Impact factor: 6.244

9.  A Case of Isolated Myeloid Sarcoma Associated With Germline EGFR T790M Variant: The Importance of Recognizing Potential Germline Variants on Somatic Tumor Sequencing Panels.

Authors:  Margaret Walker; Matthew Folstad; Kelcy Smith-Simmer; Erica Reinig; Kalyan Nadiminti; Lauren Lovrien; Jane E Churpek; Lauren G Banaszak
Journal:  J Hematol       Date:  2022-04-12

10.  Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study.

Authors:  Lei Lei; Wen-Xian Wang; You-Cai Zhu; Jin-Luan Li; Yong Fang; Hong Wang; Wu Zhuang; Yin-Bin Zhang; Li-Ping Wang; Mei-Yu Fang; Chun-Wei Xu; Xiao-Jia Wang; Tang-Feng Lv; Yong Song
Journal:  Cancer Sci       Date:  2020-01-16       Impact factor: 6.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.